IRadimed Corporation (IRMD) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.
The consensus price target is $120.00, representing an upside of 28.3% from the current price $93.56.
Analysts estimate Earnings Per Share (EPS) of $1.66 and revenue of $0.07B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.52 vs est $1.66 (missed -8.4%). 2025: actual $1.77 vs est $1.87 (missed -5.1%). Analyst accuracy: 93%.
IRMD Stock — 12-Month Price Forecast
$120.00
▲ +28.26% Upside
Average Price Target
Based on 2 Wall Street analysts offering 12-month price targets for IRadimed Corporation, the price target is $120.00.
The average price target represents a +28.26% change from the last price of $93.56.
IRMD Analyst Ratings
Buy
Based on 2 analysts giving stock ratings to IRadimed Corporation in the past 3 months
EPS Estimates — IRMD
93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.52
vs Est $1.66
▼ 9.2% off
2025
Actual $1.77
vs Est $1.87
▼ 5.4% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — IRMD
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.073B
vs Est $0.073B
▲ 0.3% off
2025
Actual $0.084B
vs Est $0.083B
▲ 1.3% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
